Niacin therapy improves outcome and normalizes metabolic abnormalities in an NAXD-deficient patient.
Manor J, Calame DG, Gijavanekar C, Tran A, Fatih JM, Lalani SR, Mizerik E, Parnes M, Mehta VP, Adesina AM, Lupski JR, Scaglia F, Elsea SH.
Manor J, et al. Among authors: mizerik e.
Brain. 2022 Jun 3;145(5):e36-e40. doi: 10.1093/brain/awac065.
Brain. 2022.
PMID: 35231119
No abstract available.